“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

Committed until the End: Final Meeting of CoMMiTMenT

October 02, 2018

The CoMMiTMenT consortium at the final meeting in Zurich, Switzerland

The CoMMiTMenT consortium met for the project’s final meeting at the Institute of Veterinary Physiology of the University of Zurich on September 18-19. CoMMiTMenT coordinator Lars Kaestner (Saarland University) welcomed representatives from all project partners as well as Dr Paola Bianchi (Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico), who joined the consortium as external advisor.

The latest progress regarding the project objectives were discussed during both meeting days. Some significant steps were taken in the last months of CoMMiTMenT, especially regarding MeCheM, the device developed in lieu of the µCOSMOS device, and the Scanning Ion Conductance Microscope. The development of both machines has been slightly delayed due to unforeseen difficulties but both are now taken into operation and delivering the expected results. Despite the challenges on the way, the consortium is confident to bring this FP7 project to a successful end.

On the first meeting day, external advisor Dr Paola Bianchi gave a very well-received presentation entitled “Congenital hemolytic anaemias: what a mutation can teach us”. The consortium was able to draw some parallels to their findings which led to in-depth discussion on the research of anaemias.

The project has officially ended on 30 September 2018, but the consortium hopes to continue their important work on rare anaemias in one way or another.